Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Sarcoma 1Rhabdomyosarcoma 1Rhabdoid Tumor 1Retinoblastoma 1Neoplasms, Germ Cell and Embryonal 1Medulloblastoma 1Hepatoblastoma 1Central Nervous System Neoplasms 1Carcinoma, Renal Cell 1Brain Neoplasms 1

Interventions

Thiotepa 2Melphalan 2Granulocyte Colony-Stimulating Factor 2Busulfan 2etoposide phosphate 1entinostat 1Ursodeoxycholic Acid 1Tamoxifen 1Radiotherapy 1Radiation 1Quality of Life 1Peripheral Blood Stem Cell Transplantation 1Patient Reported Outcome Measures 1Paclitaxel 1Molecular Diagnostic Techniques 1Mesna 1Leukapheresis 1Itraconazole 1Immunotherapy 1Immunologic Techniques 1Ifosfamide 1Filgrastim 1Fentanyl 1Etoposide 1Erlotinib Hydrochloride 1Drug Therapy 1Doxorubicin 1Cisplatin 1Carboplatin 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × Ursodeoxycholic Acid × Other solid neoplasm × Clear all
NCT01505569 2024-02-26

Auto Transplant for High Risk or Relapsed Solid or CNS Tumors

Masonic Cancer Center, University of Minnesota

Phase NA Completed
44 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Brain Neoplasms, Carcinoma, Renal Cell, Medulloblastoma, Neoplasms, Germ Cell and Embryonal, Retinoblastoma, Rhabdomyosarcoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡